160 related articles for article (PubMed ID: 37408032)
1. The effects of functional foods mixture on inflammatory cytokines and biochemical findings in hospitalized patients with COVID-19: a randomized double-blind controlled trial.
Gouvarchinghaleh HE; Kiany F; Parastouei K; Alishiri G; Jafari NJ; Fooladi AAI; Pargar A; Ghazvini A; Mirnejad R; Raei M; Olounabadi AS; Babaei M; Heydari S; Rostami H; Shahriary A; Farnoosh G; Sobhani V; Mazhari MM; NajjarAsiabani F
Trials; 2023 Jul; 24(1):442. PubMed ID: 37408032
[TBL] [Abstract][Full Text] [Related]
2. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
[TBL] [Abstract][Full Text] [Related]
4. The effect of vitamin D and magnesium supplementation on clinical symptoms and serum inflammatory and oxidative stress markers in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Ramezani-Jolfaie N; Eftekhar E; Dadinasab M; Hesarooeyeh ZG; Pakdaman P; Razmpour F; Javedan G; Khayatian M; Azad MH; Davoodian P; Brahimi E; Rafati S; Nikoofal-Sahlabadi S; Mohammadi M
Trials; 2023 Feb; 24(1):87. PubMed ID: 36747270
[TBL] [Abstract][Full Text] [Related]
5. Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial.
Yousefi M; Sadriirani M; PourMahmoudi A; Mahmoodi S; Samimi B; Hosseinikia M; Saeedinezhad Z; Panahande SB
Trials; 2021 Apr; 22(1):246. PubMed ID: 33810808
[TBL] [Abstract][Full Text] [Related]
6. Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Tutunchi H; Mobasseri M; Pourmoradian S; Soleimanzadeh H; Kafil B; Akbari N; Monshikarimi A; Ostadrahimi A
Trials; 2020 Oct; 21(1):890. PubMed ID: 33109244
[TBL] [Abstract][Full Text] [Related]
7. The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
Hassaniazad M; Inchehsablagh BR; Kamali H; Tousi A; Eftekhar E; Jaafari MR; Fathalipour M; Nikoofal-Sahlabadi S; Gouklani H; Alizade H; Nikpoor AR
Trials; 2020 Oct; 21(1):876. PubMed ID: 33092653
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Samimagham HR; Hassani Azad M; Haddad M; Arabi M; Hooshyar D; KazemiJahromi M
Trials; 2020 Oct; 21(1):848. PubMed ID: 33050945
[TBL] [Abstract][Full Text] [Related]
11. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial.
Doaei S; Gholami S; Rastgoo S; Gholamalizadeh M; Bourbour F; Bagheri SE; Samipoor F; Akbari ME; Shadnoush M; Ghorat F; Mosavi Jarrahi SA; Ashouri Mirsadeghi N; Hajipour A; Joola P; Moslem A; Goodarzi MO
J Transl Med; 2021 Mar; 19(1):128. PubMed ID: 33781275
[TBL] [Abstract][Full Text] [Related]
12. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S
Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.
Hafizi M; Kalanaky S; Fakharzadeh S; Karimi P; Fakharian A; Lookzadeh S; Mortaz E; Mirenayat MS; Heshmatnia J; Karam MB; Zamani H; Nadji A; Toutkaboni MP; Oraee-Yazdani S; Akbari ME; Jamaati H; Nazaran MH
Trials; 2023 Nov; 24(1):720. PubMed ID: 37951972
[TBL] [Abstract][Full Text] [Related]
14. Inflawell
Barzin Tond S; Balenci L; Khajavirad N; Salehi M; Tafakhori A; Shahmohammadi MR; Ghiasvand F; Jafari S; Abolghasemi S; Mokhtari F; Mahmoodi Baram S; Zarei T; Kazemi D; Mohammadnejad E; Shah-Hosseini A; Haghbin Toutounchi A; Fallah S; Riazi A; Karima S
Inflammopharmacology; 2022 Apr; 30(2):465-475. PubMed ID: 35201518
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
16. Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Safa O; Hassani-Azad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
Trials; 2020 Sep; 21(1):790. PubMed ID: 32933552
[TBL] [Abstract][Full Text] [Related]
17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
18. Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Miryan M; Bagherniya M; Sahebkar A; Soleimani D; Rouhani MH; Iraj B; Askari G
Trials; 2020 Dec; 21(1):1027. PubMed ID: 33334357
[TBL] [Abstract][Full Text] [Related]
19. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
20. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]